Ascorbate: Clinical Trials

5 trials of Ascorbate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 13Completed 3

Follow Ascorbate: new trials by email Literature Review of Ascorbate trials Research Report on Ascorbate

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Ascorbate - Soft Tissue Sarcoma
Phase 1 / Phase 2CompletedMohammed Milhem252019-06-272026-06-18
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
Gemcitabine, nab-paclitaxel, Pharmacological ascorbate - Pancreatic Neoplasms, Cancer of Pancreas
Phase 2CompletedUniversity of Iowa402018-11-282026-07-23
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
Vitamin C - Myelodysplastic Syndromes
Phase 1 / Phase 2CompletedNYU Langone Health42018-05-012024-03-27
Pharmacological Ascorbate for Lung Cancer
Paclitaxel, Carboplatin, Ascorbic Acid - Carcinoma, Non-Small-Cell Lung
Phase 2CompletedJoseph J. Cullen, MD, FACS552015-04-012024-08-20
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Ascorbic Acid + Sorafenib, Sorafenib - Metastatic Hepatocellular Carcinoma, Advanced Liver Cancer
Phase 1 / Phase 2CompletedThomas Jefferson University52012-09-012025-05-04

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Liver Neoplasms (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)

Sponsors

Joseph J. Cullen, MD, FACS (1)  ·  Mohammed Milhem (1)  ·  NYU Langone Health (1)  ·  Thomas Jefferson University (1)  ·  University of Iowa (1)

Countries

United States (5)

Top investigators

Joseph J. Cullen, MD, FACS (2)  ·  Daniel A Monti, MD, MBA (1)  ·  Mohammad M Abdul Hay, MD (1)  ·  Mohammed Milhem, MBBS (1)

Results publications

PMID 28366679, PMID 35525024, PMID 39369582

NIH funding

P30CA086862 (2), P01CA217797 (1), U01CA140206 (1)